Differential increase in natriuretic peptides in elite dynamic and static athletes

Circulation Journal

Volumn 67, Issue 8, 2003, Pages 691-696

  Date, Haruhiko ^a   Imamura, Takuroh ^a   Onitsuka, Hisamitsu ^a   Maeno, Masakazu ^a   Watanabe, Reiko ^a   Nishihira, Kensaku ^a   Matsuo, Takeshi ^a   Eto, Tanenao ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Athlete's heart; Atrial natriuretic peptide; Brain natriuretic peptide

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; ATHLETE; CONTROLLED STUDY; CORRELATION ANALYSIS; DECELERATION; DIASTOLE; DYNAMIC EXERCISE; HEART EJECTION FRACTION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE WALL; HUMAN; MORPHOLOGY; MULTIVARIATE ANALYSIS; NORMAL HUMAN; PREDICTION; PROTEIN BLOOD LEVEL; RUNNING; STATIC EXERCISE;

EID: 0042594394     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.67.691     Document Type: Article

References (32)

1. Raskoff WJ, Goldman S, Cohn K. The 'athletic heart': Prevalence and physiologyical significance of left ventricular enlargement in distance runner. JAMA 1976; 236: 158-162.
2. Mitchell JH, Haskell W, Raven PB. Classification of sports. J Am Coll Cardiol 1994; 24: 864-866.
3. Kangawa K, Matsuo H. Purification and complete amino acid sequence of a-human atrial natriuretic polypeptide. Biochem Biophys Res Commun 1984; 118: 131-139.
4. de Bold AJ. Atrial natriuretic factor: A hormone produced by the heart. Science 1985; 230: 767-770.
5. Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature 1988; 332: 78-81.
6. Yoshimura M, Yasue H, Okumura K Ogawa H, Jougasaki M, Mukoyama M, et al. Different secretion pattern of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 1993; 87: 464-469.
7. Nishikimi T, Yoshihara F, Morimoto A, Ishikawa K, Ishimitsu T, Saito Y, et al. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension 1996; 28: 22-30.
8. Hasegawa K, Fujiura H, Doyama K, Miyamae M, Fujiwara T, Suga S, et al. Ventricular expression of brain natriuretic peptide in hypertrophic cardiomyopathy. Circulation 1993; 88: 373-380.
9. Yasue H, Obata K, Okumura K, Kurose M, Ogawa H, Matsuyama K, et al. Increased secretion of atrial natriuretic polypeptide from the left ventricle in patients with dilated cardiomyopathy. J Clin Invest 1989; 83: 46-51.
10. Ogawa K, Oida A, Sugimura H, Kaneko N, Nogi N, Hasumi M, et al. Clinical significance of blood brain natriuretic peptide level measurement in the detection of heart disease in untreated outpatients: Comparison of electrocardiography, chest radiography and echocardiography. Circ J 2002; 66: 122-126.
11. Imamura Y, Fukuyama T, Mochizuki T, Miyagawa M, Watanabe K. Prognostic value of iodine-123-metaiodobenzylguanidine imaging and cardiac natriuretic peptide levels in patients with left ventricular dysfunction resulting from cardiomyopathy. Jpn Circ J 2001; 65: 155-160.
12. 123I-metaiodobenzylguanidine imaging in patients with dilated cardiomyopathy with congestive heart failure before and after optimized treatments: Comparison with neurohumoral factors. Circ J 2002; 66: 537-543.
13. ACC/AHA guideline for the clinical application of echocardiography: Executive summary. A report of the American College of Cardiology/American Heart Association Task force on practice guidelines (Committee on Clinical Application of Echocardiography). J Am Coll Cardiol 1997; 29: 862-879.
14. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Circulation 1977; 55: 613-618.
15. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-367.
16. Grossman W, Jones D, McLaurin LP. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 1975; 56: 56-64.
17. Hama N, Nakao K, Mukoyama M, Suga S, Ogawa Y, Kawabata Y, et al. Fundamental and clinical evaluation of 'Shionoria ANP', human atrial natriuretic peptide IRMA kit. Clin Report 1991; 25: 455-462.
18. Yasue H, Yoshimura M, Jougasaki M, Itoh H, Suga S, Ogawa Y, et al. Plasma levels of brain natriuretic peptide in normal subjects and patients with chronic heart failure; measurement by immunoradiometric assay (IRMA). Horm Clin 1993; 41: 397-403.
19. Mukoyama M, Nakao K, Hosoda S, Suga S, Saito Y, Ogawa Y, et al. Brain natriuretic peptide (BNP) as a novel cardiac hormone in humans: Evidence for an exquisite dual natriuretic peptide system, ANP and BNP. J Clin Invest 1991; 87: 1402-1412.
20. Hosoda K, Nakao K, Mukoyama M, Saito Y, Jougasaki M, Shirakami G, et al. Expression of brain natriuretic peptide gene in human heart. Production in the ventricle. Hypertension 1991; 17: 1152-1155.
21. Imamura T, McDermott P, Kent R, Nagatsu M, Cooper G IV, Carabello BA. Acute changes in myosin heavy chain synthesis rate in pressure versus volume overload. Circ Res 1994; 75: 418-425.
22. Nakagawa O, Ogawa Y, Itoh H, Suga S, Komatsu Y, Kishimoto I, et al. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy: Evidence for brain natriuretic peptide as an 'emergency' cardiac hormone against ventricular overload. J Clin Invest 1995; 96: 1280-1287.
23. Saito Y, Nakao K, Arai H, Nishimura K, Okumura K, Obata K, et al. Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart. J Clin invest 1989; 83: 298-305.
24. Bloch KD, Seidman JG, Naftilan JD, Fallon JT, Seidman CE. Neonatal atria and ventricles secrete atrial natriuretic factor via tissue-specific secretory pathway. Cell 1986; 47: 695-702.
25. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natfiuretic peptide in normal subjents and patients with heart failure. Circulation 1994; 90: 195-203.
26. Fouad FM, Slominski JM, Tarazi RC. Left ventricular diastolic function in hypertension: Relation to left ventricular mass and systolic function. J Am Coll Cardiol 1984; 3: 1500-1506.
27. Roman MJ, Devereux RB, Atlas SA, Pini R, Ganau A, Hochreiter C, et al. Relationship of atrial natriuretic factor to left ventricular volume and mass. Am Heart J 1989; 118: 1236-1242.
28. Clerico A, Del Ry S, Maffei S, Prontera C, Emdin M, Giannessi D. The circulating levels of cardiac neatriuretic hormones in healthy adults: Effects of age and sex. Clin Chem Lab Med 2002; 40: 371-377.
29. Hirata Y, Matsumoto A, Aoyagi T, Yamaoki K, Komuro I, Suzuki T, et al. Measurement of plasma brain natriuretic peptide level as a guide for cardiac overload. Cardiovasc Res 2001; 51: 585-591.
30. Nousiainen T, Jantunen E, Vanninen E, Remes J, Vuolteenaho O, Hartikainen J. Natriuretic peptides as markers of cardiaotoxicity during doxorubicin treatment for non-Hogkin's lymphoma. Eur J Haematol 1999; 62: 135-141.
31. Suzuki T, Hayashi D, Yamazaki T, Mizuno T, Kanda Y, Komuro I, et al. Elevated B-type natriuretic peptide levels after anthracycline administration. Am Heart J 1998; 136: 362-363.
32. Huston TP, Puffer JC, Rodney WM. The athletic heart syndrome. N Engl J Med 1985; 313: 24-32.